Combination of 0.1 to 1 mg of SGC Stimulator of at least one selected from a defined Group with 2.5 to 20 mg a PDE5 inhibitor selected from another group； Pharmaceutical formulation that comprises and use in the treatment of Male Sexual Dysfunction.
SANDNER PETER,STACH JOHANNES PETER, BOTTECHER MICHAEL FRIEDRICH.
申请号：
CL2011001712
公开号：
CL2011001712A1
申请日:
2011.07.14
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
Combination of 0.1 to 1 mg of SGC Stimulator of at least one selected from a defined Group with 25 to 20 mg a PDE5 inhibitor selected from another group； Pharmaceutical formulation that comprises and use in the treatment of Male Sexual Dysfunction.Combinación de 0,1 a 1 mg de al menos un estimulador de sgc seleccionado de un grupo definido con 2,5 a 20 mg de un inhibidor de pde5 seleccionado de otro grupo； formulación farmacéutica que la comprende y uso en el tratamiento de la disfunción sexual masculina.
